Logipharma 2015 (past event)
19 - 21 April, 2016
Contact Us: 44 (0) 207 368 9465
Wednesday 15th April 2015 - Main Conference Day One
08:00 - 08:45 Registration and welcome coffee
08:45 - 09:00 Chairman’s opening address and business card exchange
Manel Luis
Director, EMEA Warehousing, Global Manuacturing and SupplyBristol Myers Squibb
09:00 - 09:30 OPENING KEYNOTE Our story: Reimagining the supply chain strategy to optimise performance for a highly complex portfolio
- What decisions are being made to change the supply chain department structure to retain a capacity balance?
- How are key decisions made on supply chain strategy following a merger or acquisition?
- How to ensure transparency of information across the chain to assess and then implement practical changes
- How do we balance quality versus speed and cost – which company-wide decision making criteria and metrics have worked well?
Simon Orchard
Vice President, EMEA Supply Operations & Customer Support, Global Supply ChPfizer
09:30 - 10:10 COMMUNITY FORUM: Innovative methods to integrate downstream and upstream to release working capital and increase efficiency - Synchronising commercial, distribution, planning, manufacturing and packing
- Proven examples of how integrating downstream and upstream can release working capital
- Which innovative methods have worked in integrating downstream and upstream?
- How to supply chain transparency to measure the financial impact of the supply chain
- What methods have work well and not so well in measuring the financial impact?
Marcin Lamowski
Operations Director ECEMEABaxter
10:10 - 10:30 Turning theory into practice: End-to-end distribution network optimization - strategies, tools and approaches for a complicated and evolving portfolio
- Outlining the main differences in supply chain requirements for biopharma portfolio versus a standard care portfolio
- Examining the decision making criteria behind what to change – what were the main priorities and how were they decided?
- Exploring markets were consolidated into hubs – what were the main challenges and how were they overcome?
- Effectively consolidating service providers and how to renegotiate contracts to match new strategies
- Establishing a sustainable change-enabled customer-centric distribution network
Christele Galpin Hadjadj
Executive Director, EMEAI Logistics Management & Global Logistics IntegrateBristol Myers Squibb
10:30 - 11:10 Morning Networking Break/ Master Class
MASTER CLASS: Trade Compliance: Understanding how to comply with global trade regulation and legal policies in today’s international supply chains
Nick Boland, Director of Solutions Consulting EMEA, Amber Road
11:10 - 23:35 Redefining the supply chain strategy to ensure efficiency in a growing and more complex environment
- How do you balance the trade-off between cost efficiency and agility/speed in more global, volatile and product-diverse supply chains - what are the key drivers and strategies?
- How to segment your supply chain, considering evolving product portfolio and customer requirements (e.g. new temperature-control requirements versus those for standard drug products)?
- Which enablers need to be implemented in a company-wide supply chain setup (e.g. organization, IT, processes)?
- Introduction to success factors, validated through concrete case examples
Susanne Amholt
VP Business Development Life Sciences & Healthcare Mainland EuropeDHL Supply Chain
Thorsten Roggenbuck
VP Global Account Management Life Science & Health CareDHL Supply Chain
23:35 - 11:55 Exploring ground transportation methods for a global supply chain – what’s been successful, what’s been a challenge, and what can be learned for the future?
- Examining what’s worked well with ground transportation methods – and how this should change supply chain strategy
- Benchmarking ground transportation methods globally – what’s been learned?
- How to overcome the main challenges in global ground transportation methods
- What are the future predictions for ground transportation methods, and how should pharma supply chain prioritise their investment?
Sue Lee
Technical Portfolio ManagerWorld Courier
11:55 - 12:35 IN-DEPTH INTERVIEW: How to earn a place in the board room - a new type of supply chain
- Developing a different supply chain value proposition with focus on innovation, growth, and agility
- Measuring supply chain impact relevant to the business - from cost and capital reduction to top-line and margin optimization
- Effectively communicating supply chain strategy and value case to the board
Networking lunch
12:35 - 13:45 Networking LunchMaster Class 1
12:35 - 13:45 How to set up an effective customer driven S&OP process
An invaluable opportunity for you to turn theory into practice by applying your knowledge in an experienced classroom environment. Each master class is moderated by a leading practitioner and is open to a 25 – 30 active participants who form part of a high level interactive discussion. Join a master class and take part in the conversation to move your industry forward.
- How to set-up a robust S&OP process design
- Understanding the concept of concrete building blocks to explore the process
- Examining methods that have a proven track record, including pharmaceutical customer examples
- Real-life examples of how these building blocks can achieving concrete business benefits including: Improved forecast accuracy, lower inventories, cost efficiency and improved availability
Master Class 2
12:35 - 13:45 Supply Chain Vision 2020
Lunch will be served in the masterclass room.
An invaluable opportunity for you to turn theory into practice by applying your knowledge in an experienced classroom environment. Each master class is moderated by a leading practitioner and is open to a 25 – 30 active participants who form part of a high level interactive discussion. Join a master class and take part in the conversation to move your industry forward.
13:45 - 13:50 Choose your Track: A, B or C
New distribution channels
13:50 - 14:00 Chairman’s opening addressInnovation in security, integrity, track and trace
13:50 - 14:00 Chairman’s opening addressAdvancing integrated planning
13:50 - 14:00 Chairman’s opening addressTRACK A
14:00 - 14:20 Evolving from cost cutting to value creation: Creating innovative distribution concepts by combining commercial and logistics thinking- Using the e-channel to foster and speed up distribution of individualized dosing and combinations
- Combining multi-channel marketing with logistics and distribution When just in time to treatment adds additional value to patients and physicians
- Open additional value creation engaging pharmacies in customer-centric value adding services
- Creating alliances while sharing gained additional benefit throughout new distribution models
TRACK B
14:00 - 14:20 EFPIA working group address: Implementing a strategy to manage the practical impacts of global serialisation requirements including the EU Falsified Medicines Directive- The global serialization challenge and how it impacts the industry's operations as well as the country's healthcare system.
- A focus on the EU Falsified Medicines Directive. What's happening next in Europe ?
- The importance of having a strategic approach
TRACK C
14:00 - 14:20 CASE STUDY INTERACTIVE: How to implement a strategy for effective end-to-end supply chain planning-
What real-time metrics should you put in place to manage volume, requirement and regulatory changes?
-
What strategies can you put in place to bridge the gap between the API and raw material supplier to the customer?
-
How should planning synchronise and communicate more effectively with distribution to release working capital?
TRACK A
14:20 - 14:40 COMMUNITY FORUM: How should you choose the most effective channel in new markets to provide the best quality of service to the customer: Wholesalers vs. distributors vs. direct to patients?
Speakers:
Mirko Senatore Head of EMEA Business Solutions Pfizer
Manel Luis Director, EMEA Warehousing, Global Manuacturing and Supply Bristol Myers Squibb
Barbara Polek Senior Director Supply Chain Management & Distribution Santhera Pharmaceuticals
Roeland Vandebrouck Distribution Network Director AstraZeneca
Mirko Senatore Head of EMEA Business Solutions Pfizer
Manel Luis Director, EMEA Warehousing, Global Manuacturing and Supply Bristol Myers Squibb
Barbara Polek Senior Director Supply Chain Management & Distribution Santhera Pharmaceuticals
Roeland Vandebrouck Distribution Network Director AstraZeneca
- Determining what criteria for channels should be considered when moving into new markets
- What are the pros and cons of each channel strategy?
- What are the benefits and risks of going to wholesalers vs. distributors vs. direct to patients?
- Implementing key performance indicators (KPIs) to bring the right quality of service to the customer
Manel Luis
Director, EMEA Warehousing, Global Manuacturing and SupplyBristol Myers Squibb
Barbara Polek
Senior Director Supply Chain Management & DistributionSanthera Pharmaceuticals
TRACK B
14:20 - 14:40 CASE STUDY INTERACTIVE: Innovative technologies for serialisation – what really works and what’s practical cost-wise?- How would you best assess which serialisation equipment and technologies are available?
- Which vendor companies have you used that you might recommend to work with?
- How would you assess what’s practical in terms of cost versus meeting requirements?
TRACK C
14:20 - 14:40 Stream C continuedTRACK A
14:40 - 15:00 Stream A continuedTRACK B
14:40 - 15:00 Stream B continuedTRACK C
14:40 - 15:00 Implementing analytics reporting and flexibility – accessing business intelligence, big data: How to gain benefit from a global KPI and reporting systemHow to use business intelligence to connect fragmented systems and enable global reporting
-
Successfully implementing change management and processes to support system connections
-
How to obtain meaningful KPIs: Ensuring consistency of data from different systems; what needs to be put in place?
-
Examining the GATOR project and has successfully improved the supply chain IT TechOps strategy
-
Exploring how GATOR can be used to move from S&OP and allow future IBP (Integrated Business Plan) processes
Cecilia Moyano
Global Supply Chain Business Intelligence Managerat a leading Pharma Company
TRACK A
15:00 - 15:20 Achieving closer collaboration between manufacturers and wholesalers in the CEETRACK B
15:00 - 15:20 Innovative and smart packaging solutions: How to address real challenges in the pharmaceutical supply chain- How innovative packaging solutions can help to meet regulatory requirements
- Real life examples of how the packaging features have prevented product diversion
- Exploring how temperature control tracking can be integrated with security requirements
- What are the main challenges in implementing the packaging solutions and how to overcome them
TRACK C
15:00 - 15:20 Stream C continued15:20 - 15:50 Afternoon networking break
The time efficient way to get your fix of security, integrity, track and trace solutions; four of the most forward-thinking and exciting solution providers will provide you with a snapshot of how their technologies can help you to meet the latest requirements.
TRACK A
15:50 - 16:10 How to optimize your warehouse solution for different distribution channels: wholesale distribution versus direct-to-pharmacy or direct-to-patient - what can be learned from the retail- and E-commerce industry?Michiel Veenman
Global Solution Manager Pharmaceutical IndustrySwisslog Warehouse & Distribution Solutions
TRACK B
15:50 - 16:10 Meeting serialization requirements in 2015 and beyond – staying flexible while tackling global complexities• Observations from leading pharma companies: what are the greatest challenges in pharma serialization to date?
• Winning strategies: What is key to keep in mind to fulfill serialization requirements globally today and tomorrow?
• How to stay on top with upcoming changing regulations, deal with many uncertainties and keep focus on the main strategic direction
TRACK C
15:50 - 16:10 Building supply chain planning end-to-end sustainability: Achieving success through Bristol-Myers Squibb’s Supply Planning Process Center of Excellence- Examining the main capabilities of the Supply Planning Process Center of Excellence and how it can be used in end-to-end sustainability
- How to ensure local adoption, and knowledge for global-scale planning processes and systems
- What strategies can be implemented to prevent the risk of stock-out?
- Ensuring effective communication with local business agencies, wholesalers and internal units in the final mile of distribution
Track A - New distribution channels
16:10 - 16:30 How to successfully synchronise new packaging solutions with transportation strategies across different distribution channelsTRACK B
16:10 - 16:30 DRILL-DOWN ROUND TABLES: Benchmarking and improving practical methods for security track and trace
These informal subject-specific roundtables give you a unique opportunity to drill down into the details of the software and technologies for integrated planning that most interest you. Each roundtable is limited to 10 people for maximum interaction and is designed for you to meet like-minded peers and source practical solutions collaboratively.
Table 1: How to overcome the problem of theft, diversion and anti-counterfeiting -
Table 2: End to end serialization
Jyrki Syvari, Corporate Director Supply Chain Integrity, Boehringer Ingelheim
Table 3: GS1 advice - How to be ready in advance of the Falsified Medicines Directive serialisation requirement
Tania Snioch, Director Healthcare, GS1
Table 4: Overview of live temperature tracking technologies for improving track & trace
Table 5: How to meet the European serialisation and traceability guidelines.
Haris Kamal, Vice President of Life Sciences, Frequentz
Skycell AG
Table 1: How to overcome the problem of theft, diversion and anti-counterfeiting -
- Which anti-counterfeiting methods are most effective – including ePedigree and eDocuments?
- What standards should be implemented for transportation?
- What methods work well for reducing the risk of diversion?
- What strategies work well for security for controlled substances?
Table 2: End to end serialization
Jyrki Syvari, Corporate Director Supply Chain Integrity, Boehringer Ingelheim
Table 3: GS1 advice - How to be ready in advance of the Falsified Medicines Directive serialisation requirement
Tania Snioch, Director Healthcare, GS1
Table 4: Overview of live temperature tracking technologies for improving track & trace
- Overview of Tracking Methods - passive & active devices, software
- Pros / Cons per technology
- Exchange on experiences - ex. Active tracking, passive tracking
- Examples on how tracking adds value
Table 5: How to meet the European serialisation and traceability guidelines.
Haris Kamal, Vice President of Life Sciences, Frequentz
Richard Ettl
CEOSkycell AG
TRACK C
16:10 - 16:30 DRILL-DOWN ROUND TABLES: Maximising opportunities in implementing innovative software and technologies for integrated planning
Speakers:
Cecilia Moyano Global Supply Chain Business Intelligence Manager at a leading Pharma Company
Alberto Reinoso Global Head Technical Operations IT at a leading Pharma Company
Trevor Miles VP Thought Leadership and Industry Principal, Life Sciences Kinaxis
Mark Stockley Senior Manager Cognizant
Cecilia Moyano Global Supply Chain Business Intelligence Manager at a leading Pharma Company
Alberto Reinoso Global Head Technical Operations IT at a leading Pharma Company
Trevor Miles VP Thought Leadership and Industry Principal, Life Sciences Kinaxis
Mark Stockley Senior Manager Cognizant
These informal subject-specific roundtables give you a unique opportunity to drill down into the details of the software and technologies for integrated planning that most interest you. Each roundtable is limited to 10 people for maximum interaction and is designed for you to meet like-minded peers and source practical solutions collaboratively.
Table 1: Planning software
Table 2: Data: Your Roadmap to Visibility
Table 3: Examining the use of a business intelligence tool in Supply Chain
Cecilia Moyano, Global Supply Chain Business Intelligence Manager, at a leading Pharma Company
Alberto Reinoso, Global Head Technical Operations IT, at a leading Pharma Company
at a leading Pharma Company
Table 1: Planning software
- What innovative planning software systems have been implemented and worked well?
- What are the opportunities in using cloud based technologies? Which planning software technologies are you currently looking to invest in?
Table 2: Data: Your Roadmap to Visibility
- Where are we on the data maturity curve to full Supply Chain Analytics?
- To MDM or not to MDM that is the question?
- Current reality v future state vision – how far do we need to go?
- Are we equipped to take the next step – time, skills, resources, cost? can we afford not to?
- Measuring to improve or reporting to applaud – metrics to change behaviour?
Table 3: Examining the use of a business intelligence tool in Supply Chain
Cecilia Moyano, Global Supply Chain Business Intelligence Manager, at a leading Pharma Company
Alberto Reinoso, Global Head Technical Operations IT, at a leading Pharma Company
Cecilia Moyano
Global Supply Chain Business Intelligence Managerat a leading Pharma Company
TRACK A
16:30 - 17:00 Inverting the network re-design trends in PharmaTRACK B
16:30 - 17:00 TRACK B ContinuedTRACK C
16:30 - 17:00 TRACK C Continued17:00 - 17:40 IN-DEPTH INTERVIEW: Top three practical changes to walk away with: Improving supply chain efficiency - Which innovations will work, which technologies are worth investing in and what has been learned to do differently next time?
- What innovations have been successfully implemented to increase supply chain efficiency?
- Which innovative technologies are worth investing in?
- What can you do to work most effectively with your marketing and commercial team?
- What hasn’t worked so well in terms of changing a strategy - What has been learned to do differently next time?
- What tips can you give to manage complexity, unpredictability and uncertainty?
- How you manage the launch of a new product?